{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:44:48Z","timestamp":1791834288688,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":1936,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1111\/ajt.14247","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T10:13:37Z","timestamp":1488276817000},"page":"2092-2102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Donor Specificity but Not Broadness of Sensitization Is Associated With Antibody-Mediated Rejection and Graft Loss in Renal Allograft Recipients"],"prefix":"10.1016","volume":"17","author":[{"given":"C.","family":"Wehmeier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"H\u00f6nger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Cun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Hirt-Minkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Georgalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hopfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dickenmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Steiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9170-1341","authenticated-orcid":false,"given":"S.","family":"Schaub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.14247_bib1","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/ajt.13191","article-title":"Daclizumab versus rabbit antithymocyte globulin in high-risk renal transplants: Five-year follow-up of a randomized study","volume":"15","author":"Hellemans","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14247_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ajt.13052","article-title":"Rituximab as induction therapy after renal transplantation: A randomized, double-blind, placebo-controlled study of efficacy and safety","volume":"15","author":"van den Hoogen","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14247_bib3","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1097\/01.tp.0000188300.26762.74","article-title":"Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus\/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: Results of the Atlas study","volume":"80","author":"Vitko","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14247_bib4","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.14247_bib5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(10)62318-5","article-title":"Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: An open-label, randomised, controlled trial","volume":"377","author":"Budde","year":"2011","journal-title":"Lancet"},{"key":"10.1111\/ajt.14247_bib6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.14247_bib7","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/ajt.12807","article-title":"HLA antibody detection with solid phase assays: Great expectations or expectations too great?","volume":"14","author":"Gebel","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14247_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-6143.2009.02927.x","article-title":"(CPRA): The new measure of sensitization for transplant candidates","volume":"10","author":"Cecka","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14247_bib9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1600-6143.2010.03340.x","article-title":"Calculated PRA: Initial results show benefits for sensitized patients and a reduction in positive crossmatches","volume":"11","author":"Cecka","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14247_bib10","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1111\/ajt.13355","article-title":"cPRA increases with DQA, DPA, and DPB unacceptable antigens in the Canadian cPRA calculator","volume":"15","author":"Tinckam","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14247_bib11","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/MNH.0b013e32833dfc3f","article-title":"The evolution and clinical impact of human leukocyte antigen technology","volume":"19","author":"Gebel","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1111\/ajt.14247_bib12","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/MOT.0b013e328331c169","article-title":"Utility of the virtual crossmatch in solid organ transplantation","volume":"14","author":"Amico","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1111\/ajt.14247_bib13","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/j.1600-6143.2011.03640.x","article-title":"Revisiting traditional risk factors for rejection and graft loss after kidney transplantation","volume":"11","author":"Dunn","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14247_bib14","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1432-2277.2011.01235.x","article-title":"Risk stratification by the virtual crossmatch: A prospective study in 233 renal transplantations","volume":"24","author":"Amico","year":"2011","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.14247_bib15","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1600-6143.2007.01667.x","article-title":"Pretransplant risk assessment in renal allograft recipients using virtual crossmatching","volume":"7","author":"Bielmann","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14247_bib16","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.14247_bib17","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1600-6143.2010.03093.x","article-title":"Efficacy of induction therapy with ATG and intravenous immunoglobulins in patients with low-level donor-specific HLA-antibodies","volume":"10","author":"Bachler","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14247_bib18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":"Antibody-mediated rejection criteria\u2014an addition to the Banff 97 classification of renal allograft rejection","volume":"3","author":"Racusen","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14247_bib19","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: Updates and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14247_bib20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-6143.2009.02987.x","article-title":"Banff \u201809 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups","volume":"10","author":"Sis","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14247_bib21","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1600-6143.2011.03926.x","article-title":"Banff 2011 meeting report: New concepts in antibody-mediated rejection","volume":"12","author":"Mengel","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14247_bib22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: Inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14247_bib23","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1681\/ASN.2012070664","article-title":"Donor-specific antibodies adversely affect kidney allograft outcomes","volume":"23","author":"Mohan","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.14247_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/MOT.0b013e32832ca2b8","article-title":"HLAMatchmaker-based definition of structural human leukocyte antigen epitopes detected by alloantibodies","volume":"14","author":"Duquesnoy","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1111\/ajt.14247_bib25","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/tri.12533","article-title":"Pretransplant virtual PRA and long-term outcomes of kidney transplant recipients","volume":"28","author":"Huber","year":"2015","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.14247_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.trim.2016.08.003","article-title":"Impact of pretransplant exposure to allosensitization factors generating HLA antibodies in the Luminex era","volume":"38","author":"Guichard-Romero","year":"2016","journal-title":"Transpl Immunol"},{"key":"10.1111\/ajt.14247_bib27","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/TP.0b013e318186d87b","article-title":"\u201cNatural\u201d human leukocyte antigen antibodies found in nonalloimmunized healthy males","volume":"86","author":"Morales-Buenrostro","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14247_bib28","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/cei.12127","article-title":"The significance of pretransplant donor-specific antibodies reactive with intact or denatured human leucocyte antigen in kidney transplantation","volume":"173","author":"Otten","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/ajt.14247_bib29","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/MOT.0000000000000218","article-title":"T-cell alloreactivity and transplantation outcome: A budding role for heterologous immunity?","volume":"20","author":"van den Heuvel","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1111\/ajt.14247_bib30","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/ndt\/gfw027","article-title":"Deceased donor kidney transplantation across donor-specific antibody barriers: Predictors of antibody-mediated rejection","volume":"31","author":"Schwaiger","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ajt.14247_bib31","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1111\/j.1600-6143.2008.02441.x","article-title":"Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation","volume":"8","author":"Burns","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14247_bib32","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ki.2010.556","article-title":"Surveillance of alloantibodies after transplantation identifies the risk of chronic rejection","volume":"79","author":"Kimball","year":"2011","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.14247_bib33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2215\/CJN.07720715","article-title":"Allocating deceased donor kidneys to candidates with high panel-reactive antibodies","volume":"11","author":"Gebel","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/ajt.14247_bib34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.humimm.2016.10.020","article-title":"New priorities: Analysis of the new kidney allocation system on UCLA patients transplanted from the deceased donor waitlist","volume":"78","author":"Hickey","year":"2017","journal-title":"Hum Immunol"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.14247","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522250928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522250928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.14247\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:18:59Z","timestamp":1761628739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522250928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1600613522250928"],"URL":"https:\/\/doi.org\/10.1111\/ajt.14247","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Donor Specificity but Not Broadness of Sensitization Is Associated With Antibody-Mediated Rejection and Graft Loss in Renal Allograft Recipients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.14247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}